Consolidated Balance Sheets (USD $)	Mar. 31, 2013	Dec. 31, 2012
ASSETS
Cash and cash equivalents	$ 0	$ 0
Total Current Assets	0	0
PROPERTY AND EQUIPMENT (NET)	5,527	8,824
MARKETABLE SECURITIES	52,491	54,624
TOTAL ASSETS	58,018	63,448
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable and accrued expenses	977,254	949,933
Accrued interest	176,691	166,982
Due to officers and directors	3,843,133	3,853,391
Convertible Notes (Net of discount)	100,000	100,000
Notes Payable	103,000	88,000
Notes payable- in default	597,860	597,860
Total Current Liabilities	5,797,938	5,756,166
Total Liabilities	5,797,938	5,756,166
STOCKHOLDERS' DEFICIT
Common stock, par value $0.001 per share,10,000,000 shares authorized; 6,730,786 and 6,680,613 issued, 5,930,786 and 5,880,613 outstanding, respectively	6,730	6,680
Additional paid-in-capital	145,906,391	145,843,081
Stock payable	22,181	0
Unearned ESOP shares	(2,176,000)	(2,176,000)
Accumulated other comprehensive income	(2,133)	0
(Deficit) Accumulated During the Development Stage	(149,497,089)	(149,366,479)
Total Stockholders' Deficit	(5,739,920)	(5,692,718)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 58,018	$ 63,448